Related Experiment Video
Updated: Jun 5, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population
Hanane Khoury1, Isla Ogilvie, Antoine C El Khoury
1BioMedCom Consultants inc,, 1405 TransCanada Highway, Suite 310, Montreal, Quebec H9P 2V9, Canada. hanane_khoury@biomedcom.org
Insights
Rotavirus gastroenteritis (RVGE) significantly impacts children under five in the Middle East and North Africa, causing high hospitalization and mortality rates. A broad-coverage rotavirus vaccine is crucial to reduce this disease burden.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Rotavirus gastroenteritis (RVGE) is a leading cause of severe diarrhea in children globally.
- Estimating the RVGE burden in children under five is critical for public health interventions in the Middle East, North Africa, and Turkey.
Purpose of the Study:
- To estimate the burden of rotavirus gastroenteritis (RVGE) in children under five years old across the Middle East, North Africa, and Turkey.
- To analyze the epidemiological characteristics and economic impact of RVGE in the specified regions.
Main Methods:
- A systematic literature search was performed for studies published between 1999 and 2009.
- Data on RVGE epidemiology, burden, and rotavirus genotypes were extracted and compared across countries.
Main Results:
- 43 studies were identified, showing RVGE prevalence in 16-61% of acute gastroenteritis cases, peaking in winter.
- RVGE-related hospitalizations ranged from 14% to 45%, with annual fatalities up to 112 per 100,000 in some areas.
- Significant economic burden was noted, with hospitalization costs between $1.8-$4.6 million annually; G1P[8] and G2P[4] were prevalent genotypes.
Conclusions:
- RVGE poses a substantial morbidity, mortality, and economic challenge in the studied regions.
- The diversity of rotavirus strains necessitates a vaccine with broad and consistent serotype coverage.
- Vaccination strategies are essential to mitigate the RVGE burden in the Middle East and North Africa.
Background:
Rotavirus gastroenteritis (RVGE) is the most common cause of severe childhood diarrhea worldwide. Objectives were to estimate the burden of RVGE among children less than five years old in the Middle East (Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Oman, Qatar, Saudi Arabia, Syria, UAE, Yemen), North Africa (Algeria, Egypt, Libya, Morocco, Tunisia) and Turkey.
Methods:
A comprehensive literature search was conducted in major databases on the epidemiology and burden of rotavirus among children less than five years old between 1999 and 2009. Data from each country was extracted and compared.
Results:
The search identified 43 studies. RVGE was identified in 16-61% of all cases of acute gastroenteritis, with a peak in the winter. RVGE-related hospitalization rates ranged from 14% to 45%, compared to 14%-28% for non-RVGE. Annually, RVGE caused up to 112 fatalities per 100,000 in certain countries in the region. Hospitalization costs ranged from $1.8 to $4.6 million annually, depending on the country. The most recent literature available showed that G1P[8] was the most prevalent genotype combination in 8 countries (range 23%-56%). G2P[4] was most prevalent in 4 countries (26%-48%). G9P[8] and G4P[8] were also frequently detected.
Conclusions:
RVGE is a common disease associated with significant morbidity, mortality, and economic burden. Given the variety and diverse rotavirus types in the region, use of a vaccine with broad and consistent serotype coverage would be important to help decrease the burden of RVGE in the Middle East and North Africa.
Related Concept Videos
Bacterial Gastroenteritis
Cholera
Poliomyelitis
Respiratory Syncytial Virus Disease
Giardiasis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

